Perinatal lethality in H19 enhancers-Igf2 transgenic mice

Molecular Reproduction and Development

Volumn 48, Issue 2, 1997, Pages 194-207

  Wise, Thomas L ^a   Pravtcheva, Dimitrina D ^a  

^a S LOUIS UNIV HLTH SCIENCES CENTER   (United States)

Author keywords

H19 enhancers; Igf2; Mammary tumors; Perinatal lethality; Transgenic mice

Indexed keywords

DNA; SOMATOMEDIN B;

ANIMAL TISSUE; ARTICLE; BECKWITH WIEDEMANN SYNDROME; BODY GROWTH; BREAST TUMOR; CLEFT PALATE; CONTROLLED STUDY; DEMETHYLATION; DISEASE PREDISPOSITION; EMBRYO; FEMALE; GENE; GENE EXPRESSION; GENOTYPE; GROWTH DISORDER; MALE; METHYLATION; MOUSE; NEWBORN; NONHUMAN; PERINATAL DEATH; PHENOTYPE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSGENE; TRANSGENIC MOUSE; TUMOR;

ANIMALS; DNA; DNA METHYLATION; ENHANCER ELEMENTS (GENETICS); FETAL DEATH; GENES, TUMOR SUPPRESSOR; HETEROZYGOTE; HOMOZYGOTE; INSULIN-LIKE GROWTH FACTOR II; MICE; MICE, TRANSGENIC; MICROINJECTIONS; MUSCLE PROTEINS; PHENOTYPE; PROMOTER REGIONS (GENETICS); RNA, UNTRANSLATED;

ANIMALIA; MUS MUSCULUS;

EID: 0030850647     PISSN: 1040452X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2795(199710)48:2<194::AID-MRD7>3.0.CO;2-N     Document Type: Article

References (78)

1. Allen N, Reik W (1992): Imprintor or imprinted. Bioessays 14:857-859.
2. Antequera F, Bird A (1993): CpG Islands. In Jost JP and Saluz HP (ed): "DNA Methylation: Molecular Biology and Biological Significance." Boston: Birkhäuser Verlag, pp 169-185.
3. Baker J, Liu J-P, Robertson EJ, Efstratiadis A (1993): Role of insulin-like growth factors in embryonic and postnatal growth. Cell 75:73-82.
4. Barlow DP, Stoger R, Herrman BG, Saito K, Ashweifer N (1991): The mouse insulin-like growth factor type-2 receptor is imprinted and closely linked to the Tme locus. Nature 349:84-87.
5. Bartolomei MS, Tilghman SM (1992): Parental imprinting of mouse chromosome 7. Sem Dev Biol 3:107-118.
6. Bartolomei MS, Zemel S, Tilghman SM (1991): Parental imprinting of the mouse H19 gene. Nature 351:153-155.
7. Bates P, Fisher R, Ward A, Richardson L, Hill DJ, Graham CF (1995): Mammary cancer in transgenic mice expressing insulin-like growth factor II (IGF-II). Br J Cancer 72:1189-1193.
8. Beckwith JB (1969): Macroglossia, omphalocele, adrenal cytomegaly, gigantism and hyperplastic visceromegaly. Birth Defects 5:183-196.
9. Boyes J, Bird A (1991): DNA methylation inhibits transcription indirectly via a methyl-CpG binding protein. Cell 64:1123-1134.
10. Brunkow ME, Tilghman SM (1991): Ectopic expression of the H19 gene in mice causes prenatal lethality. Genes Dev 5:1092-1101.
11. Butkus V, Petrauskiene L, Maneliene Z, Klimasauskas S, Laucys V, Janulaitis A (1987): Cleavage of methylated CCCGGG sequences containing either N4-methylcytosine or 5-methylcytosine with MspI, HpaII, SmaI, XmaI, Cfr9I restriction endonucleases. Nucleic Acids Res 15:7091-7102.
12. Chomczynski P, Sacchi N (1987): Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156-159.
13. Chung W-Y, Yuan L, Feng L, Hensle T, Tycko B (1996): Chromosome 11p15.5 regional imprinting: Comparative analysis of KIP2 and H19 in human tissues and Wilms' tumors. Hum Mol Genet 5:1101-1108.
14. Daughaday WH, Rotwein P (1989): Insulin-like growth factors I and II. Peptide, messenger ribonucleic acid and gene structures, serum and tissue concentrations. Endocrin Rev 10:68-91.
15. DeChiara TM, Efstratiadis A, Robertson EJ (1990): A growth deficiency phenotype in heterozygous mice carrying an insulin-like growth factor II gene disrupted by targeting. Nature 345:78-80.
16. DeChiara TM, Robertson EJ, Efstratiadis A (1991): Parental imprinting of the mouse insulin-like growth factor II gene. Cell 64:849-859.
17. Engstrom W, Lindham S, Schofield P (1988): Wiedemann-Beckwith syndrome. Eur J Pediatr 147:450-457.
18. Ferguson-Smith AC, Cattanach BM, Barton SC, Beechey CV, Surani MA (1991): Embryological and molecular investigations of parental imprinting on mouse chromosome 7. Nature 351:667-670.
19. Ferguson MWJ (1988): Palate development. Development Suppl. 103:41-60.
20. Ferguson MWJ (1994): Craniofacial malformations: towards a molecular understanding. Nature Genet 6:329-330.
21. Fiering S, Epner E, Robinson K, Zhuang Y, Telling A, Hu M, Martin DIK, Enver T, Ley TJ, Groudine M (1995): Targeted deletion of 5′ HS2 of the murine β-globin LCR reveals that it is not essential for proper regulation of the β-globin locus. Genes Dev 9:2203-2213.
22. Filson AJ, Louvi A, Efstratiadis A, Robertson EJ (1993): Rescue of the T-associated maternal effect in mice carrying null mutations in Igf-2 and Igf2r, two reciprocally imprinted genes. Development 118:731-736.
23. Forejt J, Gregorova S (1992): Genetic analysis of genomic imprinting: An Imprintor-1 gene controls inactivation of the paternal copy of the mouse Tme locus. Cell 70:443-450.
24. Frank D, Keshet I, Shani M, Levine N, Razin A, Cedar H (1991): Demethylation of CpG islands in embryonic cells. Nature 351:239-241.
25. Giannoukakis N, Deal C, Paquette J, Goodyer CG, Polychronakos C (1993): Parental genomic imprinting of the human IGF2 gene. Nature Genet 4:98-101.
26. Haig D, Trivers R (1995): The evolution of parental imprinting: A review of hypotheses. R Ohlsson, K Hall, M Ritzen (eds): "Genomic Imprinting: Causes and Consequences." Cambridge: Cambridge University Press, pp 17-28.
27. Han VKM, Land PK, Lee DC, D'Ercole AJ (1988): Expression of somatomedin/insulin-like growth factor messenger ribonucleic acids in the human fetus: Identification, characterization, and tissue distribution. J Clin Endocrinol Metab 66:422-429.
28. Haselbacher GK, Irminger J-C, Zapf J, Ziegler WH (1987): Insulin-like growth factor II in human adrenal pheochromocytomas and Wilms tumors: Expression at the mRNA and protein level. Proc Natl Acad Sci USA 84:1104-1106.
29. Hedborg F, Holmgren L, Sandstedt B, Ohlsson R (1994): The cell type-specific IGF2 expression during early human development correlates to the pattern of overgrowth and neoplasia in the Beckwith-Wiedemann syndrome. Am J Pathol 145:802-817.
30. Hogan B, Beddington R, Costantini F, Lacy E (1994): "Manipulating the Mouse Embryo: A Laboratory Manual, 2nd ed." Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press.
31. Hoovers JM, Kalikin LM, Johnson LA, Alders M, Redeker B, Law DJ, Bliek J, Steenman M, Benedict M, Wiegant J, Lengauer C, Taillon-Miller P, Schlessinger D, Edwards MC, Elledge SJ, Ivens A, Westerveld A, Little P, Mannens M, Feinberg A (1995): Multiple genetic loci within 11p15 defined by Beckwith-Wiedemann syndrome rearrangement breakpoints and subchromosomal transferable fragments. Proc Natl Acad Sci USA 92:12456-12460.
32. Hu J-F, Vu TH, Hoffman AR (1995): Differential biallelic activation of three insulin-like growth factor II promoters in the mouse central nervous system. Mol Endocrinol 9:628-636.
33. Johnson DR (1974): Hairpin-Tail: a case of post-reductional gene action in the mouse egg? Genetics 76:795-805.
34. Junien C (1992): Beckwith-Wiedemann syndrome, tumorigenesis and imprinting. Curr Opin Genet Dev 2:431-438.
35. Kafri T, Ariel M, Brandeis M, Shemer R, Urven L, McCarrey J, Cedar H, Razin A (1992): Developmental pattern of gene-specific DNA methylation in the mouse embryo and germ line. Genes Dev 6:705-714.
36. Kalscheuer VM, Mariman EC, Schepens MT, Rehder H, Ropers HH (1993): Insulin-like growth factor type 2 receptor gene is imprinted in the mouse but not in humans. Nature Genet 5:74-78.
37. Kornfeld S (1992): Structure and function of the mannose 6-phosphate/insulin-like growth factor II receptors. Ann Rev Biochem 61:307-330.
38. Kou K, Rotwein P (1993): Transcriptional activation of the insulin-like growth factor II gene during myoblast differentiation. Mol Endocrinol 7:291-302.
39. Lau MMH, Stewart CEH, Liu Z, Bhatt H, Rotwein P, Stewart CL (1994): Loss of the imprinted IGF2/cation-independent mannose 6-phosphate receptor results in fetal overgrowth and perinatal lethality. Genes Dev 8:2953-2963.
40. Lee JE, Pintar J, Efstratiadis A (1990): Pattern of the insulin-like growth factor II gene expression during early mouse embryogenesis. Development 110:151-159.
41. Lee JE, Tantravaki V, Boyle A, Efstratiadis A (1993): Parental imprinting of an Igf-2 transgene. Mol Reprod Dev 35:382-390.
42. Lee MP, Hu R-J, Johnson LA, Feinberg AP (1997): Human KVLQT1 gene shows tissue-specific imprinting and encompass is Beckwith-Wiedemann syndrome chromosomal rearrangements. Nature Genet 15:181-185.
43. Leighton P, Ingram RS, Eggenschwiler J, Efstratiadis A, Tilghman SM (1995a): Disruption of imprinting caused by deletion of the H19 gene region in mice. Nature 375:34-39.
44. Leighton PA, Saam JR, Ingram RS, Stewart CL, Tilghman SM (1995b): An enhancer deletion affects both H19 and Igf2 expression. Genes Dev 9:2079-2089.
45. Levine A, Contoni GL, Razin A (1991): Inhibition of promoter activity by methylation: Possible involvement of protein mediators. Proc Natl Acad Sci USA 88:6515-6518.
46. Liu J-P, Baker J, Perkins AS, Robertson EJ, Efstratiadis A (1993): Mice carrying null mutations of the genes encoding insulin-like growth factor I (Igf-1) and type 1 Igf receptor (Igf1r). Cell 75:59-72.
47. Ludwig T, Eggenschwiler J, Fisher P, D'Ercloe AJ, Davenport ML, Efstratiadis A (1996): Mouse mutants lacking the type 2 IGF receptor (IGF2R) are rescued from perinatal lethality in Igf2 and Igf1r null backgrounds. Dev Biol 177:517-535.
48. Mannens M, Hoovers JM, Redeker E, Verjaal M, Feinberg AP, Little P, Boavida M, Coad N, Steenman M, Bliek J, Niikawa N, Tonoki H, Nakamura Y, de Boer EG, Slater RM, John R, Cowell JK, Junien C, Henry I, Tommerup N, Weksberg R, Pueschel SM, Leschot NJ, Westerveld A (1994): Parental imprinting of human chromosome region 11p15.3-pter involved in the Beckwith-Wiedemann syndrome and various human neoplasia. Eur J Hum Genet 2:3-23.
49. Matsuguchi T, Takahashi Kikejiri K, Ueno T, Endo H, Yamamato M (1990): Functional analysis of multiple promoters of the rat insulin-like growth factor II gene. Biochem Biophys Acta 1048:165-170.
50. McCusker RH, Clemmons DR (1992): The insulin-like growth factor binding proteins: Structure and biological functions. In PN Schofield (ed): "The Insulin-like Growth Factors." New York: Oxford University Press, pp 110-150.
51. Monk M, Boubelik M, Lehnert S (1987): Temporal and regional changes in DNA methylation in the embryonic, extraembryonic, and germ cell lineages during mouse embryo development. Development 99:371-382.
52. Newell S, Ward A, Graham C (1994): Discriminating translation of insulin-like growth factor II (IGF-II) during mouse embryogenesis. Mol Reprod Dev 39:249-258.
53. Nielsen FC, Gammeltoft S, Christiansen J (1990): Translation discrimination of mRNAs coding for human insulin-like growth factor II. J Biol Chem 265:13431-13434.
54. Nielsen FC, Ostergaard L, Nielsen J, Christiansen J (1995): Growth dependent translation of IGF-II mRNA by a rapamycin-sensitive pathway. Nature 377:358-362.
55. Ohlsson R, Larsson E, Nilsson O, Wahlstrom T, Sundstrom P (1989): Blastocyst implantation precedes induction of insulin-like growth factor II gene expression in human trophoblasts. Development 106:555-559.
56. Ohlsson R, Nyström A, Pfeifer-Ohlsson S, Töhönen V, Hedborg F, Schofield P, Flam F, Ekström TJ (1993): Igf2 is parentally imprinted during human embryogenesis and in Beckwith-Wiedemann syndrome. Nature Genet 4:94-97.
57. Pilia G, Hughes-Benzie RM, MacKenzie A, Baybayan P, Chen EY, Huber R, Neri G, Cao N, Forabosco A, Schlessinger D (1996): Mutations in GPC3, a glypican gene, cause the Simpson-Golabi-Behmel overgrowth syndrome. Nature Genet 12:241-247.
58. Pravtcheva DD, Adra CN, Ruddle FH (1991): Timing of paternal PGK-1 expression in embryos of transgenic mice. Development 111:1109-1120.
59. Rappolee DA, Sturm KS, Behrendtsen O, Schultz GA, Pedersen RA, Werb Z (1992): Insulin-like growth factor II acts through an endogenous growth pathway regulated by imprinting in early mouse embryos. Genes Dev 6:939-952.
60. Razin A, Cedar H (1991): DNA methylation and gene expression. Microbiol. Rev. 55:451-458.
61. Rogler CE, Yang D, Rosetti L, Donohoe J, Alt E, Chang CJ, Rosenfeld R, Neely K, Hintz R (1994): Altered body composition and increased frequency of diverse malignancies in insulin-like growth factor transgenic mice. J Biol Chem 269:13779-13784.
62. Rotwein P, Hall LJ (1990): Evolution of insulin-like growth factor II: Characterization of the mouse IGF-II gene and identification of two pseudoexons. DNA Cell Biol 9:725-735.
63. Sambrook J, Fritsch EF, Maniatis T (1989): "Molecular Cloning: A Laboratory Manual, 2nd ed." Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press.
64. Sasaki H, Jones PA, Chaillet JR, Ferguson-Smith A, Barton SC, Reik W, Surani MA (1992): Parental imprinting: potentially active chromatin of the repressed maternal allele of the mouse insulin-like growth factor II (Igf2) gene. Genes Dev 6:1843-1856.
65. Singer C, Rassmussen A, Smith HS, Lippman ME, Lynch HT, Cullen KJ (1995): Malignant breast epithelium selects for insulin-like growth factor II expression in breast stroma: evidence for paracrine function Cancer Res 55:2448-2454.
66. Stylianopoulou F, Efstratiadis A, Herbert J, Pintar J (1988a): Pattern of insulin-like growth factor II gene expression during rat embryo-genesis. Development 103:497-506.
67. Stylianopulou F, Herbert J, Soares MB, Efstratiadis A (1988b): Expression of the insulin-like growth factor II gene in the choroid plexus and the leptomeninges of the adult rat central nervous system. Proc Natl Acad Sci USA 85:141-145.
68. Turleau C, de Grouchy J (1985): Beckwith-Wiedemann syndrome. Clinical comparison between patients with and without 11p15 trisomy. Ann Genet 28:93-96.
69. Van Buul-Offers SC, de Haan K, Reijnen-Gresnigt MG, Meinsma D, Jansen M, Oei SL, Bonte EJ, Sussenbach JS, Van den Brande JL (1995): Overexpression of human insulin-like growth factor-II in transgenic mice causes increased growth of the thymus. J Endocrinol 144:491-502.
70. Wang ZQ, Fung MR, Barlow DP, Wagner EF (1994): Regulation of embryonic growth and lysosomal targeting by the imprinted Igf2/Mpr gene. Nature 372:464-467.
71. Ward A, Bates P, Fisher R, Richardson L, Graham CF (1994): Disproportionate growth in mice with Igf2 transgenes. Proc Natl Acad Sci USA 91:10365-10369.
72. Werner HM, LeRoith D (1996): The role of the insulin-like growth factor system in human cancer. Adv. Cancer Res. 68:183-223.
73. Wiedemann HR (1983): Tumors and hemihypertrophy associated with Wiedemann-Beckwith syndrome. Eur J Pediat 141:129.
74. Winking H, Silver LM (1984): Characterization of a recombinant mouse t haplotype the expresses a dominant lethal maternal effect. Genetics 108:1013-1020.
75. Wolf E, Kramer R, Blum WF, Foll J, Brem G (1994): Consequences of postnatally elevated insulin-like growth factor II in transgenic mice: Endocrine changes and effects on body and organ growth. Endocrinology 135:1877-1886.
76. Yoo-Warren H, Pachnis V, Ingram RS, Tilghman SM (1988): Two regulatory domains flank the mouse H19 gene. Mol Cell Biol 8:4707-4715.
77. Zemel S, Bartolomei MS, Tilghman SM (1992): Physical linkage of two mammalian imprinted genes, H19 and insulin-like growth factor 2. Nature Genet 2:61-64.
78. Zhang Y, Shields T, Crenshaw T, Hao Y, Moulton T, Tycko B (1993). Imprinting of human H19: Allele-specific CpG methylation, loss of the active allele in Wilm's tumor, and potential for somatic allele switching. Am J Hum Genet 53:113-124.